This topic contains a solution. Click here to go to the answer

Author Question: The client who has received intravenous immune globulin must wait what length of time before ... (Read 148 times)

tingc95

  • Hero Member
  • *****
  • Posts: 556
The client who has received intravenous immune globulin must wait what length of time before receiving active immunization?
 
  1. 2 months
  2. 1 year
  3. 4 months
  4. 1 month

Question 2

The nurse correctly understands that the administration of the PCV vaccine should occur at which ages?
 
  1. 5 and 10 months
  2. 15 and 18 months
  3. 1, 8, 13, and 18 to 20 months
  4. 2, 4, 6, and 12 to 15 months



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bhavsar

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

Correct Answer: 3
Rationale 1: Two months is not long enough.
Rationale 2: One year is too long to wait for additional immunizations.
Rationale 3: The client must wait at least 3 to 5 months.
Rationale 4: One month is not long enough.
Global Rationale: Because this drug contains antibodies to live viruses, active vaccinations should not be given until 3 to 5 months after IVIG has been administered.

Answer to Question 2

Correct Answer: 4
Rationale 1: This is not the time frame for PCV administration.
Rationale 2: This is not the time frame for PCV administration.
Rationale 3: This is not the time frame for PCV administration.
Rationale 4: The PCV vaccine should be administered at 2, 4, 6, and 12 to 15 months.
Global Rationale: Because the administration of PPV to young children with immature immune systems leads to a poor antibody response, this vaccine is not recommended in children under 2 years of age. A second vaccine, called pneumococcal conjugate vaccine (PCV), was specially developed for routine immunization in children under the age of 2. This immunization differs from PPV in that the S. pneumoniae polysaccharides are coupled with a protein that leads to improved immune activation in infants with immature immune function. The latest form of the pneumococcal conjugate vaccine, PCV13, was approved in 2010 and protects against 13 types of pneumococcal bacteria. PCV13 is used in a series of four IM injections at 2 months, 4 months, 6 months, and 12 to 15 months.




tingc95

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
Excellent


Sarahjh

  • Member
  • Posts: 370
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

For a complete list of videos, visit our video library